Virology Division, SEALS, Prince of Wales Hospital, Randwick, NSW 2031, Australia.
J Clin Microbiol. 2011 Sep;49(9):3163-7. doi: 10.1128/JCM.02447-10. Epub 2011 Jul 13.
The storage of biological samples may affect detection of viral nucleic acid, yet the stability of viral nucleic acid at standard laboratory storage temperatures (-70°C and -20°C) has not been comprehensively assessed. Deterioration of viral RNA and DNA during storage may affect the detection of viruses, thus leading to an increased likelihood of false-negative results on diagnostic testing. The viral loads of 99 hepatitis C virus (HCV), 41 HIV, and 101 hepatitis B virus (HBV) patient samples were measured before and after storage at -20°C and -70°C for up to 9.1 years using Versant branched DNA assays, Cobas Monitor assays, and/or AmpliPrep/AmpliScreen assays. Clinical samples stored at -20°C for up to 1.2 years and at -70°C for up to 9 years showed a statistically significant difference from baseline with respect to HCV RNA titer, although this difference was not greater than 0.5 log(10) unit. The concentration of HIV RNA in clinical samples stored at -20°C for 2.3 years and at -70°C for up to 9.1 years did not differ significantly from the baseline viral load. HBV DNA-positive clinical samples stored at -20°C for up to 5 years and at -70°C for up to 4 years differed significantly in viral load. In all studies, however, the loss of viral load of HCV, HIV, or HBV in clinical samples tested after storage at -20°C and -70°C for up to 9 years ranged from 0.01 to 0.35 log(10) IU/ml and did not exceed 0.5 log(10), which is the estimated intra-assay variation for molecular tests. Hence, the loss was considered of minimal clinical impact and adequate for the detection of HCV, HIV-1, and HBV nucleic acids using nucleic acid assays for the assessment of the infectious risk of cell, blood, and tissue donors.
生物样本的储存可能会影响病毒核酸的检测,但病毒核酸在标准实验室储存温度(-70°C 和-20°C)下的稳定性尚未得到全面评估。储存过程中病毒 RNA 和 DNA 的降解可能会影响病毒的检测,从而增加诊断检测出现假阴性结果的可能性。使用 Versant 分枝 DNA 检测、Cobas Monitor 检测和/或 AmpliPrep/AmpliScreen 检测,对 99 例丙型肝炎病毒(HCV)、41 例人类免疫缺陷病毒(HIV)和 101 例乙型肝炎病毒(HBV)患者样本在-20°C 和-70°C 下储存长达 9.1 年后的病毒载量进行了测量。在-20°C 下储存长达 1.2 年和在-70°C 下储存长达 9 年的临床样本与 HCV RNA 滴度相比,具有统计学显著差异,尽管这种差异不超过 0.5 log(10)单位。在-20°C 下储存长达 2.3 年和在-70°C 下储存长达 9.1 年的临床样本中 HIV RNA 的浓度与基线病毒载量无显著差异。在-20°C 下储存长达 5 年和在-70°C 下储存长达 4 年的 HBV DNA 阳性临床样本在病毒载量方面存在显著差异。然而,在所有研究中,HCV、HIV 或 HBV 临床样本在-20°C 和-70°C 下储存长达 9 年后的病毒载量损失范围为 0.01 至 0.35 log(10) IU/ml,不超过 0.5 log(10),这是分子检测的估计实验内变异。因此,这种损失被认为具有最小的临床影响,足以使用核酸检测评估细胞、血液和组织供体的感染风险,以检测 HCV、HIV-1 和 HBV 核酸。